why choose us

First received: January 06, 2023

Clinical Trial: A Study of STAR-0215 in Participants With Hereditary Angioedema

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hereditary Angioedema

Study Type: INTERVENTIONAL


Official Title: A Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of STAR-0215 in Participants With Heredit

Brief Summary: The goal of this clinical trial is to test the drug STAR-0215 in participants with hereditary angioedema (HAE).One group of participants will get 1 dose of STAR-0215, and two other groups will get 2 doses of STAR-0215.Researchers will study the effects of STAR-0215 in participants with HAE as this is the first time that the drug has been given to participants with HAE.

Read more